{{--
  Back to User
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

Survey to assess the Prevalence & Management of Gastroesophageal Reflux Disease in Obstetrics & Gynaecology Practice

Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients on an average do you see in a day? *

  2. What is the profile of patients you typically see in your practice? *
    3. a) Most common Age Range

    b) Gender (% of patients)
    Male
    %
    Female
    %
    c) Geographic location (% of patients)
    Urban
    %
    Rural
    %
    Suburban
    %
  3. In your clinical practice, out of total patients, what percentage of your patient population comprises pregnant women? *
  4. Do you commonly encounter GERD associated with menopause in your practice? *

  5. If yes, what is the percentage of such patients out of the menopause population in your practice?

  6. How frequently do you find heartburn/reflux in pregnant women? *

  7. When treating GERD in such patients, what is the first line of treatment? *
    8. Lifestyle modification: Please mention the kind of lifestyle modification/(s) commonly suggested:
    Pharmacotherapy
    Both
  8. Do you change your GERD treatment approach based on the trimester in patients? *

  9. If yes, please elaborate the approach
  10. What is the 1st line of therapy for treating GERD in your practice? *

  11. According to you what is the current trend in managing APD (acid-peptic disease)? *

  12. Which of the following drugs do you prefer most to treat GERD? *

  13. Please list some common conditions you encounter in your practice? *
    14. A.
    B.
    C.
    D.
    E.
    F.
    G.
    H.
  14. In which conditions do you prescribe an antacid in your practice? *
  15. What percentage of your patients are prescribed antacid drugs? *
  16. In your clinical practice, in which indications do you prescribe or co-prescribe PPI the most? *
    17. Condition Rate the usage (1-Low, 2-Medium, 3-High)
  17. How often do you encounter patients with refractory APD (i.e., symptoms persist despite treatment)? *

  18. There is need to create awareness about GERD in Menopause *

  19. How do you usually raise awareness about GERD in your patients? *

  20. In which class of drugs listed below do you consider co-prescribing PPI? *

  21. Which PPI do you prefer in patients with GERD and co-morbidities? *

  22. Do you encounter APD in patients taking antibiotics or undergoing Hormone Replacement Therapy? *

  23. What are the typical dietary patterns or habits observed in patients with APD? *

  24. What challenges do you face in managing patients with APD in your practice? *

  25. In which situation in GERD patients do you prefer combining PPI and prokinetics? *
  26. Which Prokinetic agent do you generally choose to incorporate? *

  27. How do you stay updated on the latest advancements and incorporate them into your clinical practice? (Latest Guidelines/Recent evidence/Doctors Group Meetings/social media/Medical Conferences) *
  28. Which guidelines do you refer to when treating gynecological conditions? *
    29. A.
    B.
    C.
    D.
  29. What strategies do you use to promote patient adherence to lifestyle modifications & medication? *
    30. A.
    B.
    C.
    D.